QMS Medicosmetics GmbH has been sold to BlueGem Capital Partners
The private shareholders of QMS Medicosmetics GmbH (QMS) have sold the company to BlueGem Capital Partners LLP for an undisclosed consideration.
QMS is a leading premium skin care brand, founded in 1986 by the renowned German former facial surgeon Dr. Erich Schulte. Over the years, Dr. Schulte has formulated a range of 35 scientifically advanced, high performance products, which are appreciated around the world for their efficacy. QMS is almost exclusively available in the spa channel, with in-house developed treatments as well as retail products. There are over 700 QMS locations worldwide, including in some of the world’s best hotels, as well as Liberty in London and KaDeWe in Berlin.
BlueGem Capital Partners LLP is a London based mid-market private equity manager established in 2007, which invests equity in medium- sized business in selected countries in Western Europe.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.



Dr Erich Schulte
Founder, QMS Medicosmetics GmbH
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn moreTerra Holding S.r.l. has launched a voluntary public tender offer for Gibus S.p.A.
Terra Holding S.r.l. has initiated a voluntary public tender offer for the shares of Gibus S.p.A.
Learn more